Deficient Beta-Glucosidase Activity
Significantly reduced enzyme function confirms the genetic metabolic defect defining the disease.
A blood sample is drawn and the white blood cells are isolated. The cells are then tested in a laboratory to quantify how effectively the enzyme breaks down glucocerebroside.
Significantly reduced enzyme function confirms the genetic metabolic defect defining the disease.